Cargando…
Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis
BACKGROUND: Atrial fibrillation (AF) is common in hypertrophic cardiomyopathy (HCM). There is limited data regarding the outcomes of AF catheter ablation in HCM patients. In this study, we aimed to synthesize all available evidence on the effectiveness of ablation of AF in patients with HCM compared...
Autores principales: | Ezzeddine, Fatima M, Agboola, Kolade M, Hassett, Leslie C, Killu, Ammar M, Del-Carpio Munoz, Freddy, DeSimone, Christopher V, Kowlgi, Gurukripa N, Deshmukh, Abhishek J, Siontis, Konstantinos C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498139/ https://www.ncbi.nlm.nih.gov/pubmed/37595138 http://dx.doi.org/10.1093/europace/euad256 |
Ejemplares similares
-
Atrial fibrillation ablation in end-stage renal Disease:...Yes, we can!
por: Kowlgi, Gurukripa N., et al.
Publicado: (2021) -
Hybrid Catheter-Based and Surgical Techniques for Ablation of Ventricular Arrhythmias
por: Khalil, Fouad, et al.
Publicado: (2020) -
Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis
por: Memon, Areeba, et al.
Publicado: (2023) -
Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis
por: Christian, Susan, et al.
Publicado: (2022) -
One-year outcomes of catheter ablation for atrial fibrillation in young patients
por: Tseng, Andrew S., et al.
Publicado: (2023)